All News

Article

Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis

Bella Mehta, MBBS, MS Dec 01, 2020

Although arthritis-related activity, disabling work limitations, and severe pain (which are indications for TKA) disproportionately impact African American patients compared to White patients, there are marked racial disparities documented in utilization and complications in unilateral total knee arthroplasty.

IVIg in Dermatomyositis: Dr. Sheila Reyes ( @RHEUMarampa) reviews abstract #0995 presented at #ACR20. https://t.co/PKYATqUh0d

https://bit.ly/2VoVVZq

#BestACR20Tweets RT @KDAO2011 : Very strong push by #ACR20 to recc MTX in most RA patient scenarios including RA ILD, RA nodules, NAFLD in new RA guidance document @rheumnow

Citrulline Reactive B Cells Present in Lungs of Risk, Early RA: Richard Conway ( @RichardPAConway) discusses ACR abstract #1445 presented #ACR20 https://t.co/WjcBPay86P https://t.co/JnUVss0FDK

https://bit.ly/37rMhdV

#BestACR20Tweets RT @DrMiniDey : Patient-physician discordance seen in ~30% RA patients starting #DMARDs - ↑Patient-reported pain; functional impairment assoc. w/ discordance - Patient-centric treatment discussions needed to reduce discordance Abs#1978 https://t.co/uTJehn5Qs5 https://t.co/289d3VsE22

https://acrabstracts.org/abstract/prevalence-and-factors-associated-with-patien…

#BestACR20Tweets RT @doctorRBC : Upadacitinib vs. Adalimumab vs. PBO in PsA Phase 3 RCT ⬇️MSK symptoms, PsO, function, pain, fatigue, rads progression in UPA *⃣UPA15 non-inferior to ADA for ACR20, UPA30 superior *⃣Similar VTE in all arms #ACR20 Abs#2026 https://t.co/n5wcKK1juC

#BestACR20Tweets RT @ejdein1 : Does IL-6 blockade prevent mechanical ventilation or death in #COVID19? MGH study by Dr. Stone Abst#L07 graph shows no benefit #ACR20 https://t.co/JWa1LSIC8R https://t.co/EOEoHhmKqk

RA Risk Factors and Early RA: Dr. Jeffrey Sparks ( @jeffsparks) and Dr. Janet Pope ( @Janetbirdope) #ACR20 https://t.co/vN7Dt60R4W https://t.co/K5vAhEQfks

https://bit.ly/3lp0xsU

Dr. Kay leads an internat'l panel of rheums to elicit their opinions on key abstracts at #ACR20. Panelists: Dr. David Liew, Dr. Eric Dein, Dr. Meral El Ramahi, Dr. Richard Conway, Dr. Sheila Reyes and Dr. Jeffrey Sparks. https://t.co/Jg6QiswnnJ https://t.co/UAqiN3F734

https://bit.ly/2JkgsM8

#BestACR20Tweets FAST trial (Plenary) showed opposite of CAREs study. Febuxostat vs PBO in 6128 Gout pts, showed little dropout (~6%) in a 4 year study. Febuxostat (mean 81mg) had similar, flare rates, MACE/cardiac endpoints and CV death vs allopurinol #ACR20 Abstr#L08 https://t.co/EUXQqy3VuI

Timely video on COVID 19 and Rheumatic Disease with Dr. Jeffrey Sparks ( @jeffsparks) #acr20 https://t.co/5Qg3HRkQyW

https://bit.ly/3qcgmqF

#BestACR20Tweets RT @RichardPAConway :Dr MacDonald presents Febuxostat versus Allopurinol Streamlined Trial. 6128 patients. HR 0·89 [95% CI 0·75-1·06] for cardiovas. events in febuxostat vs allopurinol. Mortality 7.2% vs 8.6%. Reassuring re cardiovascular safety of febuxostat

Dr. Rachel Tate ( @uptoTate) reviews outpatient billing and coding pearls presented at a session at the #ACR20 meeting. https://t.co/66YbqXcncr https://t.co/PDdVKfNJYd

https://bit.ly/3mu1fqs

Check on Pneumococcal Vaccination: Dr. Janet Pope ( @Janetbirdope) #ACR20 https://t.co/D9EQ3Tl2Ot https://t.co/Zn8IVorCcs

https://bit.ly/3fNUFZg

#BestACR20Tweets RT @CreakyJoints : .@LCalabreseDO from @ClevelandClinic is discussing the science of #empathy in #rheumatology at #ACR20. How important is empathy in your doctor-patient relationship? https://t.co/dnJ3f8QouE

Revisit our #ACR20 coverage. Listen to our Day 3 part II recap. Follow the link below or find us on Apple/Android podcasts. https://t.co/1TcXfU5TMg https://t.co/hn298mJIUL

https://bit.ly/2U7iReS

#BestACR20Tweets RT @SattuiSEMD :L06: Mavrilimumab in #GCA Efficacy+safety of MAV maintaining sustained remission 26w new and relapsing/ref #GCA Flare risk ➡️ 62% risk ⬇️ of flare w/ MAV Sustained remission➡️ 33% ⬆️ in MAV No diff in new/relapsing/ref pts, No diff in AE

#BestACR20Tweets "RT @DrMiniDey : RITAZAREM trial long-term f/u -RTX vs AZA after RTX-induced remission in ANCA -RTX superior to AZA to prevent relapse -Relapse common regardless of therapy; high-dose RTX not effective beyond treatment period Abs#2052 https://t.co/cKV7qM77og

https://bit.ly/37jvsC3

Fibromyalgia Therapies Show Limited Evidence of Pain and QOL Reduction https://t.co/jpZC4KFygJ https://t.co/k7WFNQg9AY

https://bit.ly/3qcgCWF

#BestACR20Tweets RT @ejdein1 : Dr. Khanna NOVESA study #ACR20 Abst#L09. Autotaxin inhibitor ZIRI in early dcSSc. 21 pts ziri vs 12 PBO. mRSS at Wk24 mean difference -2.8. Ziri well-tolerated. Would be great for new drug for early SSc skin. @RheumNow. https://t.co/TOS9fp4gGK https://t.co/4SDisedzs3

https://bit.ly/2KGGd9N

Topics

All News

Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis

Do you get our email newsletter?